Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Infliximab ====== {{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/1BsDMEWA_ZXjDgJgIdF8fg8StAl80cRe2clktgdojTtvbfkwtJ/?limit=15&utm_campaign=pubmed-2&fc=20250319023929}} ---- **Infliximab** is a chimeric [[monoclonal antibody]] (human-murine) that inhibits **[[tumor necrosis factor]]-alpha ([[TNFα]])**. It is used to treat [[autoimmune disease]]s driven by this inflammatory [[cytokine]]. ===== Indications ===== Infliximab is used to treat several chronic inflammatory diseases, including: - **Rheumatologic diseases:** - [[Rheumatoid arthritis]] see [[Infliximab for rheumatoid arthritis]] - Ankylosing spondylitis - Psoriatic arthritis - **Inflammatory bowel diseases:** - Crohn's disease - Ulcerative colitis - **Dermatological conditions:** - Severe plaque psoriasis ===== Mechanism of Action ===== Infliximab specifically binds to **TNF-α**, blocking its activity and reducing inflammation. This helps alleviate symptoms and slow disease progression. ---- Types of immunosuppressants include Biologics such as [[adalimumab]] (Humira®) and [[infliximab]] (Remicade®). Calcineurin inhibitors such as [[tacrolimus]] (Envarsus XR® or Protopic) and [[cyclosporine]] (Gengraf®, Neoral® or Sandimmune®). Corticosteroids ([[prednisone]]) ---- infliximab.txt Last modified: 2025/03/19 06:55by 127.0.0.1